-
1.SOLID DOSAGE FORMS OF VALSARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE AND METHOD OF MAKING THE SAME 有权
标题翻译: 瓦尔塔坦,阿莫迪汀和氢氯酸的固体剂型及其制备方法公开(公告)号:US20120164218A1
公开(公告)日:2012-06-28
申请号:US13342533
申请日:2012-01-03
申请人: Yu Cao , Yatindra Joshi , Ping Li , Madhusudhan Pudipeddi , Alan Edward Royce , Robert Frank Wagner , Jiahao Zhu
发明人: Yu Cao , Yatindra Joshi , Ping Li , Madhusudhan Pudipeddi , Alan Edward Royce , Robert Frank Wagner , Jiahao Zhu
IPC分类号: A61K31/549 , A61P9/12 , A61P9/04 , A61P9/10 , A61K9/28 , A61P9/00 , A61P7/00 , A61P25/00 , A61P25/28 , A61K9/20 , A61P1/16
CPC分类号: A61K9/2054 , A61K9/209 , A61K31/41 , A61K31/4422 , A61K31/549 , A61K2300/00
摘要: Monolayer, bilayer and trilayer solid dosage forms of a combination of valsartan, amlodipine and hydrochlorothiazide are made.
摘要翻译: 制备缬沙坦,氨氯地平和氢氯噻嗪组合的单层,双层和三层固体剂型。
-
2.
公开(公告)号:US08435563B2
公开(公告)日:2013-05-07
申请号:US13342533
申请日:2012-01-03
申请人: Yu Cao , Yatindra Joshi , Ping Li , Madhusudhan Pudipeddi , Alan E Royce , Robert F Wagner , Jiahao Zhu
发明人: Yu Cao , Yatindra Joshi , Ping Li , Madhusudhan Pudipeddi , Alan E Royce , Robert F Wagner , Jiahao Zhu
摘要: Monolayer, bilayer and trilayer solid dosage forms of a combination of valsartan, amlodipine and hydrochlorothiazide are made.
-
3.Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the same 有权
标题翻译: 缬沙坦,氨氯地平和氢氯噻嗪的固体剂型及其制备方法公开(公告)号:US08475839B2
公开(公告)日:2013-07-02
申请号:US13342533
申请日:2012-01-03
申请人: Yu Cao , Yatindra Joshi , Ping Li , Madhusudhan Pudipeddi , Alan E Royce , Robert F Wagner , Jiahao Zhu
发明人: Yu Cao , Yatindra Joshi , Ping Li , Madhusudhan Pudipeddi , Alan E Royce , Robert F Wagner , Jiahao Zhu
CPC分类号: A61K9/2054 , A61K9/209 , A61K31/41 , A61K31/4422 , A61K31/549 , A61K2300/00
摘要: Monolayer, bilayer and trilayer solid dosage forms of a combination of valsartan, amlodipine and hydrochlorothiazide are made.
摘要翻译: 制备缬沙坦,氨氯地平和氢氯噻嗪组合的单层,双层和三层固体剂型。
-
4.SOLID DOSAGE FORMS OF VALSARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE AND METHOD OF MAKING THE SAME 审中-公开
标题翻译: 瓦尔塔坦,阿莫迪汀和氢氯酸的固体剂型及其制备方法公开(公告)号:US20100003321A1
公开(公告)日:2010-01-07
申请号:US11915096
申请日:2007-06-26
申请人: Yu Cao , Yatindra Joshi , Ping Li , Madhusudhan Pudipeddi , Alan E. Royce , Robert F. Wagner , Jiahao Zhu
发明人: Yu Cao , Yatindra Joshi , Ping Li , Madhusudhan Pudipeddi , Alan E. Royce , Robert F. Wagner , Jiahao Zhu
IPC分类号: A61K31/549 , A61K9/20 , A61P9/00 , A61P25/00
CPC分类号: A61K9/2054 , A61K9/209 , A61K31/41 , A61K31/4422 , A61K31/549 , A61K2300/00
摘要: Monolayer, bilayer and trilayer solid dosage forms of a combination of valsartan, amlodipine and hydrochlorothiazide are made.
摘要翻译: 制备缬沙坦,氨氯地平和氢氯噻嗪组合的单层,双层和三层固体剂型。
-
5.SOLID DOSAGE FORMS OF VALSARTAN AND AMLODIPINE AND METHOD OF MAKING SAME 审中-公开
标题翻译: VALSARTAN和AMLODIPINE的固体剂型及其制备方法公开(公告)号:US20100303906A1
公开(公告)日:2010-12-02
申请号:US12852542
申请日:2010-08-09
CPC分类号: A61K9/209 , A61K9/2027 , A61K9/2054 , A61K9/2095 , A61K31/41 , A61K31/4422 , A61K45/06
摘要: Monolayer and bilayer solid dosage forms of a combination of valsartan and amlodipine are made.
摘要翻译: 制备缬沙坦和氨氯地平组合的单层和双层固体剂型。
-
6.SOLID DOSAGE FORMS OF VALSARTAN AND AMLODIPINE AND METHOD OF MAKING THE SAME 审中-公开
标题翻译: VALSARTAN和AMLODIPINE的固体剂型及其制备方法公开(公告)号:US20120177733A1
公开(公告)日:2012-07-12
申请号:US13403638
申请日:2012-02-23
CPC分类号: A61K9/209 , A61K9/2027 , A61K9/2054 , A61K9/2095 , A61K31/41 , A61K31/4422 , A61K45/06
摘要: Monolayer and bilayer solid dosage forms of a combination of valsartan and amlodipine are made.
摘要翻译: 制备缬沙坦和氨氯地平组合的单层和双层固体剂型。
-
7.Solid Dosage Forms of Valsartan and Amlo Dipine and Method of Making the Same 审中-公开
标题翻译: 缬沙坦和Amlo Dipine的固体剂型及其制备方法公开(公告)号:US20080171086A1
公开(公告)日:2008-07-17
申请号:US11914159
申请日:2006-08-15
IPC分类号: A61K9/28 , A61K31/455 , A61P9/00 , A61K9/20
CPC分类号: A61K9/209 , A61K9/2027 , A61K9/2054 , A61K9/2095 , A61K31/41 , A61K31/4422 , A61K45/06
摘要: Monolayer and bilayer solid dosage forms of a combination of valsartan and amlodipine are made.
摘要翻译: 制备缬沙坦和氨氯地平组合的单层和双层固体剂型。
-
公开(公告)号:US20110105620A1
公开(公告)日:2011-05-05
申请号:US12987726
申请日:2011-01-10
申请人: Tomoyuki Oomura , Madhusudhan Pudipeddi , Colleen Ruegger , Alan Edward Royce , Masaki Sasaki , Tokuhiro Tamura
发明人: Tomoyuki Oomura , Madhusudhan Pudipeddi , Colleen Ruegger , Alan Edward Royce , Masaki Sasaki , Tokuhiro Tamura
IPC分类号: A61K31/137 , A61K47/10 , A61K47/02
CPC分类号: A61K31/145 , A61K9/0053 , A61K9/2013 , A61K9/2018 , A61K9/2054 , A61K9/4858 , A61K9/4866 , A61K31/135 , A61K31/137 , A61K31/138 , A61K45/06 , A61K47/10 , A61K47/26 , A61K2300/00
摘要: A solid pharmaceutical composition suitable for oral administration, comprising: (a) S 1 P receptor agonist; and (b) a sugar alcohol.
摘要翻译: 一种适用于口服给药的固体药物组合物,其包含:(a)S 1 P受体激动剂; 和(b)糖醇。
-
9.SOLID PHARMACEUTICAL COMPOSITIONS COMPRISING A SIP RECEPTOR AGONIST AND A SUGAR ALCOHOL 有权
标题翻译: 包含SIP受体激动剂和糖醇的固体药物组合物公开(公告)号:US20080311188A1
公开(公告)日:2008-12-18
申请号:US12189323
申请日:2008-08-11
申请人: Tomoyuki Oomura , Madhusudhan Pudipeddi , Colleen Ruegger , Alan Edward Royce , Masaki Sasaki , Tokuhiro Tamura
发明人: Tomoyuki Oomura , Madhusudhan Pudipeddi , Colleen Ruegger , Alan Edward Royce , Masaki Sasaki , Tokuhiro Tamura
CPC分类号: A61K31/145 , A61K9/0053 , A61K9/2013 , A61K9/2018 , A61K9/2054 , A61K9/4858 , A61K9/4866 , A61K31/135 , A61K31/137 , A61K31/138 , A61K45/06 , A61K47/10 , A61K47/26 , A61K2300/00
摘要: A solid pharmaceutical composition suitable for oral administration, comprising: (a) a S1P receptor agonist; and (b) a sugar alcohol.
摘要翻译: 一种适用于口服给药的固体药物组合物,其包含:(a)S1P受体激动剂; 和(b)糖醇。
-
公开(公告)号:US20140255497A1
公开(公告)日:2014-09-11
申请号:US14285808
申请日:2014-05-23
申请人: Tomoyuki Oomura , Madhusudhan Pudipeddi , Colleen Ruegger , Alan Edward Royce , Masaki Sasaki , Tokuhiro Tamura
发明人: Tomoyuki Oomura , Madhusudhan Pudipeddi , Colleen Ruegger , Alan Edward Royce , Masaki Sasaki , Tokuhiro Tamura
IPC分类号: A61K47/26 , A61K31/145 , A61K9/00
CPC分类号: A61K31/145 , A61K9/0053 , A61K9/2013 , A61K9/2018 , A61K9/2054 , A61K9/4858 , A61K9/4866 , A61K31/135 , A61K31/137 , A61K31/138 , A61K45/06 , A61K47/10 , A61K47/26 , A61K2300/00
摘要: A solid pharmaceutical composition suitable for oral administration, comprising: (a) S 1 P receptor agonist; and (b) a sugar alcohol.
摘要翻译: 一种适用于口服给药的固体药物组合物,其包含:(a)S 1 P受体激动剂; 和(b)糖酒精。
-
-
-
-
-
-
-
-
-